13 of the hedge funds we track hold DRUG, worth $194.6M combined as of the Q2 2026 13F filings (preliminary, still landing).
Versus the prior quarter: 4 opened a new position, 4 added, 2 trimmed, 3 exited.
8 of those are hedged quant multi-strategy books, not directional conviction.